Transrectal colour Doppler ultrasonography for quantifying angiogenesis in prostate cancer

被引:59
作者
Shigeno, K [1 ]
Igawa, M [1 ]
Shiina, H [1 ]
Kishi, H [1 ]
Urakami, S [1 ]
机构
[1] Shimane Med Univ, Dept Urol, Izumo, Shimane 693, Japan
关键词
prostate cancer; colour Doppler ultrasonography; angiogenesis; prognosis;
D O I
10.1046/j.1464-410X.2003.03068.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVE To assess the correlation between angiogenesis and Doppler signal intensity using transrectal colour Doppler ultrasonography (CDUS) in patients with prostate cancer. PATIENTS AND METHODS The study comprised 56 patients who underwent radical prostatectomy and had untreated tumours with a volume of> 0.1 mL in the peripheral zone. CDUS images were recorded on videotape before surgery. The Doppler signal intensity in tumours was evaluated using the colour pixel intensity (PI). Microvessel density (MVD) and vascular endothelial growth factor (VEGF) immunoreactivity were determined in the prostatectomy specimens. Microvessels were identified by immunohistochemical staining of endothelial cells for CD31. RESULTS The PI in the tumour correlated with MVD (P < 0.001) and increased with higher levels of VEGF immunoreactivity (P = 0.004). There was no correlation between Gleason score and MVD or PI in the tumour. CONCLUSION Blood flow assessed by CDUS may reflect the state of angiogenesis in prostate cancer. CDUS may be a useful technique for predicting tumour progression or prognosis, and may be useful for monitoring the effects of anti-angiogenic agents in the future.
引用
收藏
页码:223 / 226
页数:4
相关论文
共 28 条
[1]
Tissue factor expression and angiogenesis in human prostate carcinoma [J].
Abdulkadir, SA ;
Carvalhal, GF ;
Kaleem, Z ;
Kisiel, W ;
Humphrey, PA ;
Catalona, WJ ;
Milbrandt, J .
HUMAN PATHOLOGY, 2000, 31 (04) :443-447
[2]
CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy [J].
Bettencourt, MC ;
Bauer, JJ ;
Sesterhenn, IA ;
Connelly, RR ;
Moul, JW .
JOURNAL OF UROLOGY, 1998, 160 (02) :459-465
[3]
Borre M, 2000, CLIN CANCER RES, V6, P1882
[4]
The role of color Doppler and staging biopsies in prostate cancer detection [J].
Bree, RL .
UROLOGY, 1997, 49 (3A) :31-34
[5]
Advances in angiogenesis research: Relevance to urological oncology [J].
Campbell, SC .
JOURNAL OF UROLOGY, 1997, 158 (05) :1663-1674
[6]
Cheng WF, 1999, CANCER, V85, P651, DOI 10.1002/(SICI)1097-0142(19990201)85:3<651::AID-CNCR15>3.0.CO
[7]
2-9
[8]
Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer [J].
Duque, JLF ;
Loughlin, KR ;
Adam, RM ;
Kantoff, PW ;
Zurakowski, D ;
Freeman, MR .
UROLOGY, 1999, 54 (03) :523-527
[9]
Edgren M, 1999, ANTICANCER RES, V19, P869
[10]
ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31